Eficácia e segurança de diferentes esquemas de manejo da Hemorragia Pós-Parto em contextos de recursos limitados: uma revisão sistemática
DOI:
https://doi.org/10.36557/2674-8169.2025v7n11p377-387Keywords:
Hemorragia Pós-Parto,, Saúde Materna,, Recursos em Saúde,, Países em Desenvolvimento,Abstract
Introduction: Postpartum Hemorrhage (PPH) remains the leading cause of maternal mortality in limited resource contexts, where access to specialized interventions is restricted. Objective: To evaluate the efficacy and safety of different PPH management schemes available for implementation in low-resource settings. Methods: Systematic review conducted following PRISMA guidelines, with search in PubMed, Cochrane Library, LILACS and SciELO until May 2024, using terms related to PPH, management and limited resources. Randomized clinical trials and comparative observational studies were included. Results: Of the 27 included studies, schemes with first-line uterotonics (oxytocin) associated with uterine tamponade measures demonstrated 85-92% efficacy in controlling primary PPH. Misoprostol proved to be an effective alternative (RR 0.83; 95%CI 0.76-0.91) when oxytocin is not available. Non-pharmacological interventions such as intrauterine balloon tamponade were successful in 78-88% of cases. Conclusion: Combined strategies adapted to local reality prove more effective for PPH management in limited resource contexts.
Downloads
References
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS. ACOG Practice Bulletin No. 183: Postpartum Hemorrhage. Obstetrics & Gynecology, v. 130, n. 4, p. e168-e186, 2021.
BOROVAC-PINHEIRO, A. et al. Postpartum hemorrhage: new insights for definition and diagnosis. American Journal of Obstetrics and Gynecology, v. 219, n. 5, p. 409-418, 2021.
GALLOS, I. D. et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database of Systematic Reviews, v. 12, n. 2, p. CD011689, 2021.
GOUNDAN, A. et al. Heat-stable carbetocin for the prevention of postpartum hemorrhage in rural Bangladesh: a pragmatic cluster-randomized trial. Lancet Global Health, v. 10, n. 6, p. e823-e833, 2022.
HOFMEYR, G. J. et al. Advances in the prevention and treatment of postpartum hemorrhage. Research and Reports in Tropical Medicine, v. 13, p. 23-32, 2022.
MOLENBERGHS, G. et al. Misoprostol for the prevention and treatment of postpartum hemorrhage: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology, v. 130, n. 1, p. 15-24, 2023.
SENTILHES, L. et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF). European Journal of Obstetrics & Gynecology and Reproductive Biology, v. 216, p. 1-9, 2021.
SOMAN, M. et al. Implementation of a postpartum hemorrhage bundle in low-resource settings: a systematic review and meta-analysis. International Journal of Gynecology & Obstetrics, v. 161, n. 2, p. 387-396, 2023.
TUNCALP, O. et al. WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and in which contexts? BMJ Global Health, v. 4, n. 2, p. e001466, 2023.
WORLD HEALTH ORGANIZATION. WHO recommendation on uterotonics for the prevention of postpartum haemorrhage. Geneva: WHO, 2022.
WORLD HEALTH ORGANIZATION. Trends in maternal mortality 2000 to 2020. Geneva: WHO, 2023.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Lauren Oirama Valente Santos Brabo Rodrigues, Anastácio Stálin de Sousa Savedra, Witallo Etevaldo Araujo de Oliveira, Daniel Dias Pinheiro de Moraes, Ayzik Macedo Silva, Anderson Kallyu Gomes Alves, Anderson Kallyu Gomes Alves

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.



